Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bladder Cancer

  Free Subscription


Articles published in Urology

Retrieve available abstracts of 79 articles:
HTML format
Text format



Single Articles


    September 2019
  1. AJAJ R, Berlin A, Klaassen Z, Chandrasekar T, et al
    Age differences in patient-reported psychological and physical distress symptoms in bladder cancer patients - A Cross Sectional Study.
    Urology. 2019 Sep 2. pii: S0090-4295(19)30786.
    PubMed     Text format     Abstract available


    August 2019
  2. LIN-BRANDE M, Pearce SM, Ashrafi AN, Nazemi A, et al
    Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer.
    Urology. 2019 Aug 14. pii: S0090-4295(19)30721.
    PubMed     Text format     Abstract available


  3. KAUSHIK D, Wang H, Michalek J, Liss MA, et al
    Chemoradiation Versus Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Propensity Score-Weighted Comparative Analysis Using the National Cancer Database.
    Urology. 2019 Aug 8. pii: S0090-4295(19)30701.
    PubMed     Text format     Abstract available


    June 2019
  4. TOBERT CM, Nepple KG, McDowell BD, Charlton ME, et al
    COMPLIANCE WITH AMERICAN UROLOGICAL ASSOCIATION GUIDELINES FOR NON-MUSCLE INVASIVE BLADDER CANCER REMAINS POOR: ASSESSING FACTORS ASSOCIATED WITH NON-COMPLIANCE AND SURVIVAL IN A RURAL STATE.
    Urology. 2019 Jun 25. pii: S0090-4295(19)30562.
    PubMed     Text format     Abstract available


  5. PATEL KR, Taylor BL, Khani F, Guzzo TJ, et al
    Impact of Neoadjuvant Chemotherapy on Concordance of PD-L1 Staining Fidelity between the Primary Tumor and Lymph Node Metastases in Bladder Cancer.
    Urology. 2019 Jun 12. pii: S0090-4295(19)30528.
    PubMed     Text format     Abstract available


  6. CORBETT CJ, Xia L, Mamtani R, Malkowicz SB, et al
    Survival Benefit Persists with Delayed Initiation of Adjuvant Chemotherapy following Radical Cystectomy for Locally Advanced Bladder Cancer.
    Urology. 2019 Jun 11. pii: S0090-4295(19)30522.
    PubMed     Text format     Abstract available


    May 2019
  7. HAN DS, Lynch KE, Chang JW, Sirovich B, et al
    Overuse of Cystoscopic Surveillance among Patients with Low-Risk Non-Muscle-Invasive Bladder Cancer - A National Study of Patient, Provider, and Facility Factors.
    Urology. 2019 May 27. pii: S0090-4295(19)30448.
    PubMed     Text format     Abstract available


  8. DANFORTH KN, Sidell MA, Luong TQ, Yi DK, et al
    Care Quality and Variability in the Use of Intravesical Therapy for Initial Treatment of Non-Muscle Invasive Bladder Cancer within a Large, Diverse Integrated Delivery System.
    Urology. 2019 May 24. pii: S0090-4295(19)30442.
    PubMed     Text format     Abstract available


  9. HERR H
    Preventable Cancer Deaths associated with Bladder-Preservation for Muscle Invasive Bladder Cancer.
    Urology. 2019 May 6. pii: S0090-4295(19)30425.
    PubMed     Text format    


  10. BAT T, Buck DA, Nathan R, Cinquino J, et al
    Advanced Bladder Cancer Rechallenged With an Immune Checkpoint Inhibitor: A Case Report.
    Urology. 2019 May 3. pii: S0090-4295(19)30421.
    PubMed     Text format    


    April 2019
  11. MAGANTY A, Turner RM 2nd, Yabes JG, Davies BJ, et al
    Downstream Studies Following the Use of Bone Scan in the Staging of Muscle-invasive Bladder Cancer.
    Urology. 2019 Apr 18. pii: S0090-4295(19)30353.
    PubMed     Text format     Abstract available


  12. LORENZO SORIANO L, Ordaz Jurado G, Pontones Moreno JL, Villarroya Castillo S, et al
    TUMOR BUDDING: PROGNOSTIC VALUE IN MUSCLE-INVASIVE BLADDER CANCER.
    Urology. 2019 Apr 12. pii: S0090-4295(19)30344.
    PubMed     Text format     Abstract available


    March 2019
  13. MAY D, Canter DJ
    EDITORIAL COMMENT.
    Urology. 2019;125:228-229.
    PubMed     Text format    


  14. GILBERT SM
    EDITORIAL COMMENT.
    Urology. 2019;125:152-153.
    PubMed     Text format    


  15. PEREIRA JF, Pareek G, Mueller-Leonhard C, Zhang Z, et al
    The Perioperative Morbidity of Transurethral Resection of Bladder Tumor: Implications for Quality Improvement.
    Urology. 2019;125:131-137.
    PubMed     Text format     Abstract available


  16. MODI PK, Hollenbeck BK, Oerline M, Weizer AZ, et al
    Real-World Impact of Minimally Invasive Versus Open Radical Cystectomy on Perioperative Outcomes and Spending.
    Urology. 2019;125:86-91.
    PubMed     Text format     Abstract available


    February 2019
  17. ROYCE TJ, Efstathiou JA
    Editorial comment.
    Urology. 2019;124:189-190.
    PubMed     Text format    


  18. BANDARI J, Maganty A, Davies BJ
    Editorial Comment.
    Urology. 2019;124:125-126.
    PubMed     Text format    


  19. HONG P, Ding GP, Hao H, Yang KL, et al
    Laparoscopic Radical Cystectomy With Extracorporeal Neobladder: Our Initial Experience.
    Urology. 2019;124:286-291.
    PubMed     Text format     Abstract available


  20. RAGUE JT, Lee RS
    Management of High-grade, Nonmuscle Invasive Urothelial Carcinoma in a Prepubertal Patient With TURBT and Intravesical BCG.
    Urology. 2019;124:257-259.
    PubMed     Text format     Abstract available


  21. HERR H, Donat M
    Reduced Recurrence of Low-grade Papillary Bladder Tumors Associated With Asymptomatic Bacteriuria.
    Urology. 2019;124:179-182.
    PubMed     Text format     Abstract available


    January 2019
  22. GONZALEZ AN, Lipsky MJ, Li G, Rutman MP, et al
    The prevalence of bladder cancer during cystoscopy for asymptomatic microscopic hematuria.
    Urology. 2019 Jan 21. pii: S0090-4295(19)30073.
    PubMed     Text format     Abstract available


  23. LOH-DOYLE JC, Ashrafi A, Nazemi A, Ghodoussipour S, et al
    Dual Prosthetic Implantation After Radical Cystoprostatectomy and Neobladder: Outcomes of the Inflatable Penile Prosthesis and Artificial Urinary Sphincter in Bladder Cancer Survivors.
    Urology. 2019 Jan 18. pii: S0090-4295(19)30065.
    PubMed     Text format     Abstract available


  24. BAJIC P, Wolfe AJ, Gupta GN
    The Urinary Microbiome: Implications in Bladder Cancer Pathogenesis and Therapeutics.
    Urology. 2019 Jan 4. pii: S0090-4295(19)30006.
    PubMed     Text format     Abstract available


  25. HOARE D, Kiddoo D, Stryker T
    An Antenatally Detected Pure Malignant Rhabdoid Tumor of the Bladder.
    Urology. 2019;123:221-223.
    PubMed     Text format     Abstract available


  26. SYU SH, Chan KS, Hsiao CH, Chen WY, et al
    A Large Urinary Bladder Hemangioma Mimicking Urachal Cancer: A Case Report and Literature Review.
    Urology. 2019;123:224-226.
    PubMed     Text format     Abstract available


  27. KAYE DR, Ye Z, Li J, Herrel LA, et al
    The Stability of Physician-Specific Episode Costs for Urologic Cancer Surgery: Implications for Urologists Under the Merit-Based Incentive Program.
    Urology. 2019;123:114-119.
    PubMed     Text format     Abstract available


    December 2018
  28. BRISBANE WG, Holt SK, Winters BR, Gore JL, et al
    Non-Muscle Invasive Bladder Cancer Influences Physical Health Related Quality of Life and Urinary Incontinence.
    Urology. 2018 Dec 12. pii: S0090-4295(18)31312.
    PubMed     Text format     Abstract available


    November 2018
  29. KWAN ML, Leo MC, Danforth KN, Weinmann S, et al
    Factors that Influence Selection of Urinary Diversion among Bladder Cancer Patients in Three Community-Based Integrated Health Care Systems.
    Urology. 2018 Nov 21. pii: S0090-4295(18)31217.
    PubMed     Text format     Abstract available


  30. BAI S, Yao Z, Zhu X, Li Z, et al
    The feasibility and safety of reproductive organ preserving radical cystectomy for elderly female patients with muscle invasive bladder cancer: a retrospective propensity score-matched study.
    Urology. 2018 Nov 13. pii: S0090-4295(18)31139.
    PubMed     Text format     Abstract available


  31. HUGAR LA, Yabes JG, Turner RM 2nd, Fam MM, et al
    Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries with Bladder Cancer: A SEER-Medicare Analysis.
    Urology. 2018 Nov 10. pii: S0090-4295(18)31136.
    PubMed     Text format     Abstract available


    October 2018
  32. ABBOUD MA, Topham AK, Parker DC, Burks HR, et al
    Risk of Ovarian Malignancy in Patients Undergoing Radical Cystectomy for Bladder Cancer.
    Urology. 2018 Oct 22. pii: S0090-4295(18)31103.
    PubMed     Text format     Abstract available


  33. CHECK DK, Aaronson DS, Nielsen ME, Lee VS, et al
    Perioperative Intravesical Chemotherapy for Patients with Non-Muscle Invasive Bladder Cancer: Understanding the Extent of and Sources of Variation in Guideline-Recommended Use.
    Urology. 2018 Oct 22. pii: S0090-4295(18)31102.
    PubMed     Text format     Abstract available


    September 2018
  34. BUCHSER D, Zapatero A, Rogado J, Talaya M, et al
    LONG TERM OUTCOMES AND PATTERNS OF FAILURE FOLLOWING TRIMODALITY TREATMENT WITH BLADDER PRESERVATION FOR INVASIVE BLADDER CANCER.
    Urology. 2018 Sep 25. pii: S0090-4295(18)30966.
    PubMed     Text format     Abstract available


  35. KHANNA A, Yerram N, Zhu H, Kim S, et al
    "Utilization of BCG for Non-Muscle Invasive Bladder Cancer in an Era of BCG Supply Shortages".
    Urology. 2018 Sep 13. pii: S0090-4295(18)30951.
    PubMed     Text format     Abstract available


    August 2018
  36. HAN DS, Zhou W, Seigne JD, Lynch KE, et al
    Geographic Variation in Cystoscopy Rates for Suspected Bladder Cancer between Female and Male Medicare Beneficiaries.
    Urology. 2018 Aug 20. pii: S0090-4295(18)30835.
    PubMed     Text format     Abstract available


  37. LOTAN Y
    Editorial Comment.
    Urology. 2018;118:111-112.
    PubMed     Text format    


  38. RAYN KN, Ritchie C, Folio LR, Stamatakis L, et al
    Bilateral Ureteroenteric Strictures: A Case of the "Reverse 7".
    Urology. 2018;118:e3-e4.
    PubMed     Text format     Abstract available


    June 2018
  39. FONTENOT PA JR, Barnes BD, Parker WP, Wyre H, et al
    Postoperative Outcomes After Radical Cystectomy in Patients With Prior Pelvic Radiation.
    Urology. 2018;116:131-136.
    PubMed     Text format     Abstract available


  40. BROCKMAN JA, Vetter J, Peck V, Strope SA, et al
    Effect of a Radical Cystectomy Care Pathway on Postoperative Length of Stay and Outcomes.
    Urology. 2018;116:125-130.
    PubMed     Text format     Abstract available


    May 2018
  41. TAPIERO S, Helfand A, Kedar D, Yossepowitch O, et al
    Patient Compliance with Maintenance Intravesical Therapy for Non-Muscle Invasive Bladder Cancer.
    Urology. 2018 May 21. pii: S0090-4295(18)30473.
    PubMed     Text format     Abstract available


  42. CHALFIN HJ, Kates M, van der Toom EE, Glavaris S, et al
    Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method.
    Urology. 2018;115:82-86.
    PubMed     Text format     Abstract available


  43. ABELLO A, Delto JC, Wagner AA, Das AK, et al
    An Unusual Presentation of Metastatic Urothelial Bladder Carcinoma With Rhabdoid Features Presenting as Obstructive Uropathy.
    Urology. 2018;115:33-35.
    PubMed     Text format    


    April 2018
  44. MANO R, Goldberg H, Stabholz Y, Hazan D, et al
    Urinary Tract Infections after Urinary Diversion - Different Occurrence Patterns in Patients with Ileal Conduit and Orthotopic Neobladder.
    Urology. 2018 Apr 4. pii: S0090-4295(18)30299.
    PubMed     Text format     Abstract available


  45. ALMASSI N, Ponziano M, Goldman HB, Klein EA, et al
    Reducing Overutilization of Preoperative Medical Referrals Among Patients Undergoing Radical Cystectomy Using an Evidence-based Algorithm.
    Urology. 2018;114:71-76.
    PubMed     Text format     Abstract available


    March 2018
  46. SCHOMBURG JL, Krishna S, Cotter KJ, Soubra A, et al
    Preoperative Incidence of Deep Venous Thrombosis in Bladder Cancer Patients Undergoing Radical Cystectomy.
    Urology. 2018 Mar 15. pii: S0090-4295(18)30202.
    PubMed     Text format     Abstract available


  47. WYNER LM
    Leo Szilard's Bladder Cancer: Survival in the Nuclear Era.
    Urology. 2018 Mar 12. pii: S0090-4295(18)30178.
    PubMed     Text format    


  48. ISLAM MM, Saltzman AF, Carrasco A Jr, Higuchi T, et al
    Incidental Discovery of Adenocarcinoma of an Augmented Bladder in a Patient With Myelomenigocele Undergoing Cystolithotomy.
    Urology. 2018;113:203-205.
    PubMed     Text format     Abstract available


  49. BARLOTTA R, Edwards DC, McGreen B, Levy J, et al
    Incidental Asymptomatic Leiomyoma of the Urinary Bladder.
    Urology. 2018;113:6-9.
    PubMed     Text format    


    January 2018
  50. XIA L, Taylor BL, Mamtani R, Christodouleas JP, et al
    Associations between Travel Distance, Hospital Volume, and Outcomes Following Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer.
    Urology. 2018 Jan 2. pii: S0090-4295(17)31331.
    PubMed     Text format     Abstract available


  51. ROBINS D, Matulay J, Lipsky M, Meyer A, et al
    Outcomes Following Clinical Complete Response to Neoadjuvant Chemotherapy for Muscle-invasive Urothelial Carcinoma of the Bladder in Patients Refusing Radical Cystectomy.
    Urology. 2018;111:116-121.
    PubMed     Text format     Abstract available


  52. DIMOPOULOS P, Kampantais S, Payne S, Liyanage S, et al
    Pseudomyxoma Peritonei Arising From Urachal Mucinous Adenocarcinoma.
    Urology. 2018;111:e3-e4.
    PubMed     Text format     Abstract available


    November 2017
  53. XU H, Ma J, Chen Z, Yang J, et al
    Safety and Efficacy of en Bloc Transurethral Resection with 1.9Mum Vela Laser for Treatment of Non-Muscle-Invasive Bladder Cancer.
    Urology. 2017 Nov 30. pii: S0090-4295(17)31231.
    PubMed     Text format     Abstract available


  54. SHINDO T, Shimizu T, Nojima M, Niinuma T, et al
    Evaluation of Urinary DNA Methylation as a Marker for Recurrent Bladder Cancer: a Two-Center Prospective Study.
    Urology. 2017 Nov 28. pii: S0090-4295(17)31223.
    PubMed     Text format     Abstract available


  55. MORA VIDAL R, Regufe da Mota S, Hayden A, Markham H, et al
    EGFR Family Inhibition Identifies P38 MAPK as a Potential Therapeutic Target in Bladder Cancer.
    Urology. 2017 Nov 15. pii: S0090-4295(17)31184.
    PubMed     Text format     Abstract available


  56. GARRIDO-ABAD P, Diaz-Menendez A, Fernandez-Arjona M
    Bladder Herpes Infection in a Patient with Low-Grade Non-Muscle-Invasive Bladder Cancer.
    Urology. 2017 Nov 13. pii: S0090-4295(17)31175.
    PubMed     Text format     Abstract available


    September 2017
  57. SCHROECK FR, Patterson OV, Alba PR, Pattison EA, et al
    Development of a Natural Language Processing Engine to Generate Bladder Cancer Pathology Data for Health Services Research.
    Urology. 2017 Sep 12. pii: S0090-4295(17)30966.
    PubMed     Text format     Abstract available


    August 2017
  58. WILLIAMS SB, Huo J, Chu Y, Baillargeon JG, et al
    Cancer and All-Cause Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy: Development and Validation of a Nomogram for Treatment Decision-Making.
    Urology. 2017 Aug 25. pii: S0090-4295(17)30886.
    PubMed     Text format     Abstract available


  59. MARIAPPAN P, Lavin V, Phua CQ, Khan SAA, et al
    Predicting Grade and Stage at Cystoscopy in Newly Presenting Bladder Cancers - a Prospective Double-Blind Clinical Study.
    Urology. 2017 Aug 14. pii: S0090-4295(17)30802.
    PubMed     Text format     Abstract available


    July 2017
  60. KOO K, Zubkoff L, Sirovich BE, Goodney PP, et al
    The Burden of Cystoscopic Bladder Cancer Surveillance: Anxiety, Discomfort, and Patient Preferences for Decision Making.
    Urology. 2017 Jul 21. pii: S0090-4295(17)30754.
    PubMed     Text format     Abstract available


  61. MONCRIEF TJ, Balaji P, Lindgren B, Weight CJ, et al
    Comparative Evaluation of Bladder Specific Health Related Quality of Life (HRQOL) Instruments for Bladder Cancer.
    Urology. 2017 Jul 10. pii: S0090-4295(17)30698.
    PubMed     Text format     Abstract available


    May 2017
  62. DUNPHY KM, Garino MC, Shaw NM, Carvalho FL, et al
    When the Gold Standard Proves to be Fool's Gold - Blue Light Cystoscopy in a Case of High Risk Non-Muscle Invasive Bladder Cancer.
    Urology. 2017 May 31. pii: S0090-4295(17)30581.
    PubMed     Text format    


  63. SIHRA N, Diasuke N, Thurairaja R, Khan MS, et al
    Renal Tuberculosis Following Intravesical BCG for High-Grade Non-Muscle-Invasive Bladder Cancer.
    Urology. 2017 May 31. pii: S0090-4295(17)30587.
    PubMed     Text format     Abstract available


  64. SORIA F, Moschini M, Wirth GJ, Gust KM, et al
    Characterization of Late Recurrence after Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients.
    Urology. 2017 May 12. pii: S0090-4295(17)30487.
    PubMed     Text format     Abstract available


    April 2017
  65. LAVOIE JM, Bidnur S, Black PC, Eigl BJ, et al
    Expanding Immunotherapy Options for Bladder Cancer.
    Urology. 2017 Apr 25. pii: S0090-4295(17)30344.
    PubMed     Text format    


    March 2017
  66. TONG C, Daskalakis N, Edwards DC, Cahn DB, et al
    Malignant Infiltration of the Penis From Urothelial Carcinoma of the Bladder.
    Urology. 2017 Mar 31. pii: S0090-4295(17)30302.
    PubMed     Text format    


  67. KLAASSEN Z, Soloway MS
    EAU and AUA/SUO Guidelines on Risk Categories for Non-Muscle Invasive Bladder Cancer May Lead to Overtreatment for Low Grade Ta Bladder Tumors.
    Urology. 2017 Mar 30. pii: S0090-4295(17)30297.
    PubMed     Text format    


  68. ASHRAFI-ASGARABAD A, Ayubi E, Sullman MJ, Safiri S, et al
    Re: Hussein et al.: Development and Validation of a Quality Assurance Score for Robot-assisted Radical Cystectomy: A 10-Year Analysis (Urology 2016;97:124-129).
    Urology. 2017;101:174.
    PubMed     Text format    


    February 2017
  69. PAK JS, Lee JJ, Bilal K, Finkelstein M, et al
    Utilization Trends and Short-Term Outcomes of Robotic Versus Open Radical Cystectomy for Bladder Cancer.
    Urology. 2017 Feb 8. pii: S0090-4295(17)30124.
    PubMed     Text format     Abstract available


  70. ROBINS DJ, Sui W, Matulay JT, Ghandour R, et al
    Long-Term Survival Outcomes with Intravesical Nanoparticle Albumin-Bound Paclitaxel for Recurrent Nonmuscle Invasive Bladder Cancer after Previous Bacillus Calmette-Guerin Therapy.
    Urology. 2017 Feb 2. pii: S0090-4295(17)30046.
    PubMed     Text format     Abstract available


  71. GOROSPE L, Garcia-Santana E, Jane-Soler P, Gomez-Martinez MDV, et al
    Cardiac and Skeletal Muscle Metastases From Squamous Cell Carcinoma of the Bladder: Positron Emission Tomography-Computed Tomography Findings.
    Urology. 2017;100:e5-e6.
    PubMed     Text format     Abstract available


  72. RUBENWOLF PC, Hampel C, Roos F, Stein R, et al
    Continent Anal Urinary Diversion in Classic Bladder Exstrophy: 45-Year Experience.
    Urology. 2017;100:249-254.
    PubMed     Text format     Abstract available


  73. BREAM MJ, Maurice MJ, Altschuler J, Zhu H, et al
    Increased Use of Cystectomy in Patients 75 and Older: A Contemporary Analysis of Survival and Perioperative Outcomes From the National Cancer Database.
    Urology. 2017;100:72-78.
    PubMed     Text format     Abstract available


  74. GOLABESK T, Palou J, Rodriguez O, Parada R, et al
    Long-term Bladder and Upper Urinary Tract Follow-up Recurrence and Progression Rates of G1-2 Non-muscle-invasive Urothelial Carcinoma of the Bladder.
    Urology. 2017;100:145-150.
    PubMed     Text format     Abstract available


    January 2017
  75. CHAPPIDI MR, Kates M, Brant A, Baras AS, et al
    Assessing Cancer Progression and Stable Disease after Neoadjuvant Chemotherapy for Organ-Confined Muscle-Invasive Bladder Cancer.
    Urology. 2017 Jan 16. pii: S0090-4295(17)30031.
    PubMed     Text format     Abstract available


    December 2016
  76. SHINTANI T, Kusuhara Y, Daizumoto K, Dondoo TO, et al
    The Involvement of HGF-MET-MMP1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells.
    Urology. 2016 Dec 21. pii: S0090-4295(16)30945.
    PubMed     Text format     Abstract available


    September 2016
  77. SHIVAPPA N, Hebert JR, Rosato V, Rossi M, et al
    Dietary Inflammatory Index and Risk of Bladder Cancer in a Large Italian Case-Control Study.
    Urology. 2016 Sep 29. pii: S0090-4295(16)30637.
    PubMed     Text format     Abstract available


    April 2016
  78. PARKER WP, Toussi A, Tollefson MK, Frank I, et al
    Risk Factors and Microbial Distribution of Urinary Tract Infections Following Radical Cystectomy.
    Urology. 2016 Apr 25. pii: S0090-4295(16)30114.
    PubMed     Text format     Abstract available


    March 2016
  79. KISS B, Thoeny HC, Studer UE
    Current Status of Lymph Node Imaging in Bladder and Prostate Cancer.
    Urology. 2016 Mar 7. pii: S0090-4295(16)00182.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: